![](/img/cover-not-exists.png)
NP3 A COST-UTILITY MODEL OF TREATMENT OF NEWLY DIAGNOSED EPILEPSY IN GERMANY COMPARING TOPIRAMATE, CARBAMAZEPINE AND VALPROATE
E Remák, B SteinhoffVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65684-7
File:
PDF, 61 KB
english, 2004